Thelansis

Head and neck squamous cell carcinoma (HNSCC) is the most common cancer arising in the head and neck region. The most common risk factors are smoking, excessive drinking, and human papillomavirus (HPV) infection. The outcomes for non-metastatic HNSCC remain very encouraging and continue to improve. Advances in radiation technology and techniques, better organ-preserving surgical options, and multidisciplinary treatment modalities have improved cure rates for locally advanced HNSCC patients. The advancement of immune checkpoint inhibitors has provided significantly better outcomes, but only a small proportion of patients obtain benefits. Most recurrent and/or metastatic HNSCC patients continue to have poor survival. This has led to the vigorous investigation of new biomarkers and biomarker-based therapies. ·        Head and neck cancer is the seventh most common cancer worldwide, accounting for 3% of all cancers, with approximately 900,000 new cases and half...

 Head and neck squamous cell carcinoma (HNSCC) is the most common cancer arising in the head and neck region. The most common risk factors are smoking, excessive drinking, and human papillomavirus (HPV) infection. The outcomes for non-metastatic HNSCC remain very encouraging and continue to improve. Advances in radiation technology and techniques, better organ-preserving surgical options, and multidisciplinary treatment modalities have improved cure rates for locally advanced HNSCC patients. The advancement of immune checkpoint inhibitors has provided significantly better outcomes, but only a small proportion of patients obtain benefits. Most recurrent and/or metastatic HNSCC patients continue to have poor survival. This has led to the vigorous investigation of new biomarkers and biomarker-based therapies. ·        Head and neck cancer is the seventh most common cancer worldwide, accounting for 3% of all cancers, with approximately 900,000 new cases ...